Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Ledipasvir in HCV/HIV Co-infection
NCT02125500Phase 2Completed
- Sponsor
- ANRS
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ledipasvir, sofosbuvir in hepatitis C (HCV), sponsored by ANRS. Started Aug 2014; status: completed.
02
Drugs
ledipasvirsofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02125500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125500.